4.1 Article

Amyloid in dementia associated with familial FTLD: not an innocent bystander

Journal

NEUROCASE
Volume 22, Issue 1, Pages 76-83

Publisher

ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD
DOI: 10.1080/13554794.2015.1046458

Keywords

frontotemporal dementia; Alzheimer's disease; amyloid; MRI; FDG-PET

Funding

  1. National Institute on Aging (NIA) [U24 AG21886]
  2. NIH [RC1 AG035610, R01 AG26938, R01 AG032306, K24 AG045333, P50 AG02350, P01 AG019724-09]
  3. State of CA DHS [09-11410]
  4. John Douglas French Alzheimer's Foundation

Ask authors/readers for more resources

Patients with frontotemporal lobar degeneration (FTLD) can show superimposed amyloid pathology, though the impact of amyloid on the clinical presentation of FTLD is not well characterized. This cross-sectional case-control study compared clinical features, fluorodeoxyglucose-positron emission tomography metabolism and gray matter volume loss in 30 patients with familial FTLD in whom amyloid status was confirmed with autopsy or Pittsburgh compound B-PET. Compared to the amyloid-negative patients, the amyloid-positive patients performed significantly worse on several cognitive tests and showed hypometabolism and volume loss in more temporoparietal regions. Our results suggest that in FTLD amyloid positivity is associated with a more Alzheimer's disease-like pattern of neurodegeneration.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.1
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available